Generic versions of Eli Lilly’s Alimta (pemetrexed disodium) 100mg and 500mg concentrate for solution for infusion have begun finally to flood the market following the expiry of the originator’s US vitamin regimen patent 7,772,209 on 24 May.
The ‘209 patent had previously proven an insurmountable hurdle for would be ANDA filers seeking to enter the market ahead...




